OBJECTIVES: To evaluate the longer term changes in executive functioning among participants with cardiovascular disease (CVD) risk factors and cognitive impairments with no dementia (CIND) randomized to a diet and exercise intervention. DESIGN: A 2 (Exercise) × 2 (Dietary Approaches to Stop Hypertension [DASH] eating plan) factorial randomized clinical trial. SETTING:Academic tertiary care medical center. PARTICIPANTS: Volunteer sample of 160 older sedentary adults with CIND and at least one additional CVD risk factor enrolled in the ENLIGHTEN trial between December 2011 and March 2016. INTERVENTIONS: Six months of aerobic exercise (AE), DASH diet counseling, combined AE + DASH, or health education (HE) controls. MEASUREMENTS: Neurocognitive battery recommended by the Neuropsychological Working Group for Vascular Cognitive Disorders including measures of executive function, memory, and language/verbal fluency. Secondary outcomes included the Clinical Dementia Rating-Sum of Boxes (CDR-SB), Six-Minute Walk Distance (6MWD), and CVD risk including blood pressure, body weight, and CVD medication burden. RESULTS: Despite discontinuation of lifestyle changes, participants in the exercise groups retained better executive function 1 year post-intervention (P = .041) compared with non-exercise groups, with a similar, albeit weaker, pattern in the DASH groups (P = .054), without variation over time (P's > .867). Participants in the exercise groups also achieved greater sustained improvements in 6MWD compared with non-Exercise participants (P < .001). Participants in the DASH groups exhibited lower CVD risk relative to non-DASH participants (P = .032); no differences in CVD risk were observed for participants in the Exercise groups compared with non-Exercise groups (P = .711). In post hoc analyses, the AE + DASH group had better performance on executive functioning (P < .001) and CDR-SB (P = .011) compared with HE controls. CONCLUSION: For participants with CIND and CVD risk factors, exercise for 6 months promoted better executive functioning compared with non-exercisers through 1-year post-intervention, although its clinical significance is uncertain. J Am Geriatr Soc 68:559-568, 2020.
RCT Entities:
OBJECTIVES: To evaluate the longer term changes in executive functioning among participants with cardiovascular disease (CVD) risk factors and cognitive impairments with no dementia (CIND) randomized to a diet and exercise intervention. DESIGN: A 2 (Exercise) × 2 (Dietary Approaches to Stop Hypertension [DASH] eating plan) factorial randomized clinical trial. SETTING: Academic tertiary care medical center. PARTICIPANTS: Volunteer sample of 160 older sedentary adults with CIND and at least one additional CVD risk factor enrolled in the ENLIGHTEN trial between December 2011 and March 2016. INTERVENTIONS: Six months of aerobic exercise (AE), DASH diet counseling, combined AE + DASH, or health education (HE) controls. MEASUREMENTS: Neurocognitive battery recommended by the Neuropsychological Working Group for Vascular Cognitive Disorders including measures of executive function, memory, and language/verbal fluency. Secondary outcomes included the Clinical Dementia Rating-Sum of Boxes (CDR-SB), Six-Minute Walk Distance (6MWD), and CVD risk including blood pressure, body weight, and CVD medication burden. RESULTS: Despite discontinuation of lifestyle changes, participants in the exercise groups retained better executive function 1 year post-intervention (P = .041) compared with non-exercise groups, with a similar, albeit weaker, pattern in the DASH groups (P = .054), without variation over time (P's > .867). Participants in the exercise groups also achieved greater sustained improvements in 6MWD compared with non-Exercise participants (P < .001). Participants in the DASH groups exhibited lower CVD risk relative to non-DASH participants (P = .032); no differences in CVD risk were observed for participants in the Exercise groups compared with non-Exercise groups (P = .711). In post hoc analyses, the AE + DASH group had better performance on executive functioning (P < .001) and CDR-SB (P = .011) compared with HE controls. CONCLUSION: For participants with CIND and CVD risk factors, exercise for 6 months promoted better executive functioning compared with non-exercisers through 1-year post-intervention, although its clinical significance is uncertain. J Am Geriatr Soc 68:559-568, 2020.
Authors: Jennifer Weuve; Jae Hee Kang; JoAnn E Manson; Monique M B Breteler; James H Ware; Francine Grodstein Journal: JAMA Date: 2004-09-22 Impact factor: 56.272
Authors: Michele L Callisaya; James E Sharman; Jacqueline Close; Stephen R Lord; Velandai K Srikanth Journal: J Am Geriatr Soc Date: 2014-06-16 Impact factor: 5.562
Authors: Elena H Martínez-Lapiscina; Pedro Clavero; Estefania Toledo; Ramon Estruch; Jordi Salas-Salvadó; Beatriz San Julián; Ana Sanchez-Tainta; Emilio Ros; Cinta Valls-Pedret; Miguel Á Martinez-Gonzalez Journal: J Neurol Neurosurg Psychiatry Date: 2013-05-13 Impact factor: 10.154
Authors: J M Burns; B B Cronk; H S Anderson; J E Donnelly; G P Thomas; A Harsha; W M Brooks; R H Swerdlow Journal: Neurology Date: 2008-07-15 Impact factor: 9.910
Authors: Nikolaos Scarmeas; Jose A Luchsinger; Nicole Schupf; Adam M Brickman; Stephanie Cosentino; Ming X Tang; Yaakov Stern Journal: JAMA Date: 2009-08-12 Impact factor: 56.272
Authors: James A Blumenthal; Michael A Babyak; Alan Hinderliter; Lana L Watkins; Linda Craighead; Pao-Hwa Lin; Carla Caccia; Julie Johnson; Robert Waugh; Andrew Sherwood Journal: Arch Intern Med Date: 2010-01-25
Authors: Sarah L Aghjayan; Themistokles Bournias; Chaeryon Kang; Xueping Zhou; Chelsea M Stillman; Shannon D Donofry; Thomas W Kamarck; Anna L Marsland; Michelle W Voss; Scott H Fraundorf; Kirk I Erickson Journal: Commun Med (Lond) Date: 2022-02-17